Antonio Calles and Ernest Nadal
Mar 28, 2025, 14:56
Antonio Calles: Ernest Nadal presented Randomized Phase Il trial in 1L NSCLC at ELCC 2025
Antonio Calles, Head of the Lung Cancer Unit at Ruber International Hospital, shared a post on X:
“Randomized phase Il trial of tobemstomig (bi-specific PD1xLAG3) + platinum-based chemo vs pembrolizumab + chemo in 1L NSCLC. Presented by Ernest Nadal.
Negative trial not supporting LAG-3 combination in NSCLC.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 1, 2025, 12:48
Apr 1, 2025, 12:16
Apr 1, 2025, 12:13
Apr 1, 2025, 12:07
Apr 1, 2025, 11:53